ACD Seminar Series
RNAscope® Technology

Monday May 22, 2017

Ludwig Cancer Research, Oxford University, UK


Complete this form to register



Monday May 22, 2017

11:30 to 12:30 

Seminar Room | Old Campus Research Building | Roosevelt Drive 

Ludwig Institute for Cancer Research, Oxford University
Oxford, UK


The RNAscope® technology is being routinely used for tissue-based gene expression analysis for cancer research applications. In particular, the ultra-high sensitivity and specificity enables researchers to examine tumor heterogeneity within the tumor and in the tumor micro-environment. This technology, with its capacity to provide single-cell and single-RNA molecule sensitivity in the context of the tumor, has advanced cancer research and has been applied in over 800 publications.


Faraia Shah will present an overview on:

Visualizing gene expression and genetic variations in cancer research using RNAscope® and BaseScope™ Assays

  • Detect mRNAs and lncRNAs at single molecule sensitivity by RNAscope® assay
  • Target specific splice junctions for aberrant alternative splicing in cancers by BaseScope™ assay
  • Characterize expression profiles of various cancer markers in tumors and micro-environment
  • Case studies with PDL1, EGFR and other cancer markers will be discussed. 


Faraia Shah MPhil, PhD
Sales Account Executive
Advanced Cell Diagnostics 

Marcus Green, PhD


Space is limited.  Cakes and buns will be provided so please register for headcount.